BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27324985)

  • 1. Toward precision medicine in primary biliary cholangitis.
    Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
    Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
    Yuan Z; Jia G; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma in Primary Biliary Cholangitis.
    Sy AM; Ferreira RD; John BV
    Clin Liver Dis; 2022 Nov; 26(4):691-704. PubMed ID: 36270724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs in phase II clinical trials for primary biliary cholangitis.
    Silveira MG; Lindor KD
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1115-1121. PubMed ID: 28836457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geoepidemiology and changing mortality in primary biliary cholangitis.
    Floreani A; Tanaka A; Bowlus C; Gershwin ME
    J Gastroenterol; 2017 Jun; 52(6):655-662. PubMed ID: 28365879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach.
    Mousa HS; Carbone M; Malinverno F; Ronca V; Gershwin ME; Invernizzi P
    Autoimmun Rev; 2016 Sep; 15(9):870-6. PubMed ID: 27393766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Good prognosis in asymptomatic primary biliary cirrhosis].
    Lööf L; Lindgren S
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1396-8. PubMed ID: 20645617
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
    Levy C
    Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
    Liu BD; Qureshi K
    Dig Dis Sci; 2023 Feb; 68(2):346-348. PubMed ID: 36098875
    [No Abstract]   [Full Text] [Related]  

  • 13. Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
    Mishra AK; Singh SP
    J Hepatol; 2022 Nov; 77(5):1451. PubMed ID: 35594993
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic models in primary biliary cholangitis.
    Cristoferi L; Nardi A; Ronca V; Invernizzi P; Mells G; Carbone M
    J Autoimmun; 2018 Dec; 95():171-178. PubMed ID: 30420264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Medical Management of Primary Biliary Cholangitis.
    Rajendiran G; Mankongpaisarnrung C; Olivera-Martinez MA; McCashland TM
    S D Med; 2021 Dec; 74(12):562-568. PubMed ID: 35015947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding the cure for primary biliary cholangitis - Still waiting.
    Tanaka A; Gershwin ME
    Liver Int; 2017 Apr; 37(4):500-502. PubMed ID: 28371099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
    Aguilar MT; Carey EJ
    Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cholangitis, let's try to keep the new nomenclature correct!
    Harinck F
    Neth J Med; 2016 Jul; 74(6):229-30. PubMed ID: 27571719
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
    Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cholangitis: a comprehensive overview.
    Lleo A; Marzorati S; Anaya JM; Gershwin ME
    Hepatol Int; 2017 Nov; 11(6):485-499. PubMed ID: 29164395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.